BRUGNOLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 822
EU - Europa 214
AS - Asia 174
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 1.214
Nazione #
US - Stati Uniti d'America 816
IT - Italia 79
CN - Cina 69
SG - Singapore 53
GB - Regno Unito 28
TR - Turchia 21
DE - Germania 19
BE - Belgio 18
ID - Indonesia 18
UA - Ucraina 16
SE - Svezia 14
PL - Polonia 11
AT - Austria 10
FI - Finlandia 6
VN - Vietnam 6
CA - Canada 5
FR - Francia 4
IN - India 4
NL - Olanda 3
IE - Irlanda 2
JP - Giappone 2
AU - Australia 1
CH - Svizzera 1
EC - Ecuador 1
ES - Italia 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
RO - Romania 1
Totale 1.214
Città #
Fairfield 102
Woodbridge 92
Chandler 88
Ann Arbor 68
Ashburn 66
Santa Clara 56
Singapore 50
Houston 47
Cambridge 39
Seattle 37
Wilmington 36
Jacksonville 28
Beijing 23
Ferrara 22
Brussels 18
Jakarta 18
Princeton 14
Izmir 13
Warsaw 11
Boardman 10
Vienna 10
Milan 9
Nanjing 9
Shanghai 9
Los Angeles 7
Morciano Di Romagna 7
San Diego 7
Dong Ket 6
London 5
Nanchang 5
Cagliari 4
Cordignano 4
Falls Church 4
Ferrara di Monte Baldo 4
Shenyang 4
Bengaluru 3
Bremen 3
Des Moines 3
Toronto 3
Auburn Hills 2
Changsha 2
Dublin 2
Frankfurt am Main 2
Loerrach 2
Monterenzio 2
Muggia 2
New York 2
Norwalk 2
Orange 2
Ottawa 2
Pozzuoli 2
Redwood City 2
Rome 2
Tianjin 2
Zhengzhou 2
Addison 1
Amsterdam 1
Balasore 1
Bordeaux 1
Dearborn 1
Edinburgh 1
Eunpyeong-gu 1
Florence 1
Helsinki 1
Jiaxing 1
Lappeenranta 1
Melbourne 1
Mountain View 1
New Bedfont 1
Pamplona 1
Philadelphia 1
Piscataway 1
Prescot 1
Quito 1
San Francisco 1
Sanayi 1
Tangshan 1
Tappahannock 1
Tokyo 1
Trento 1
Vicenza 1
Washington 1
Xuzhou 1
Zurich 1
Totale 1.005
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 202
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 160
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia 134
Role of LRRK2 in the regulation of dopamine receptor trafficking 130
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia 122
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotics-Induced Weight-Gain. 120
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 55
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats 54
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease 51
Novel therapeutic targets in levodopa-induced dyskinesia: in vivo studies in rodent models of Parkinson’s disease 50
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia 49
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 48
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 44
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 34
Totale 1.253
Categoria #
all - tutte 7.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 21 17 18 20 17 17 9
2020/2021221 15 15 10 10 13 8 28 16 13 35 39 19
2021/2022129 3 12 10 3 8 13 11 14 7 12 10 26
2022/2023205 17 33 4 27 27 28 13 13 16 0 18 9
2023/202489 9 4 3 6 6 14 4 12 0 2 2 27
2024/2025175 7 16 38 6 40 68 0 0 0 0 0 0
Totale 1.253